+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pet Healthcare in Netherlands

  • PDF Icon

    Report

  • 35 Pages
  • February 2020
  • Region: Netherlands
  • MarketLine
  • ID: 5136341
Pet Healthcare in Netherlands

Summary

Pet Healthcare in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights
  • The pet healthcare market consists of retail sales of pet supplements, worming treatments, external parasite treatments, grooming products and other pet healthcare. The market is valued according to the retail selling price (RSP) and includes any applicable taxes. All currency conversions used in the creation of this report have been calculated using constant annual average 2018 exchange rates.
  • The Dutch pet healthcare market had total revenues of $159.0m in 2018, representing a compound annual growth rate (CAGR) of 1.5% between 2014 and 2018.
  • Market consumption volume increased with a CAGR of 0.5% between 2014 and 2018, to reach a total of 20 million units in 2018.
  • Stable economic conditions and rising disposable income supported the growth of market during the review period.

Scope
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pet healthcare market in the Netherlands
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pet healthcare market in the Netherlands
  • Leading company profiles reveal details of key pet healthcare market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Netherlands pet healthcare market with five year forecasts by both value and volume

Reasons to Buy
  • What was the size of the Netherlands pet healthcare market by value in 2018?
  • What will be the size of the Netherlands pet healthcare market in 2023?
  • What factors are affecting the strength of competition in the Netherlands pet healthcare market?
  • How has the market performed over the last five years?
  • Who are the top competitiors in the Netherlands's pet healthcare market?

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Category segmentation
1.6. Geography segmentation
1.7. Market share
1.8. Market rivalry
1.9. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
3.2. Market volume
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
4.3. Market distribution
5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Market share
7.2. Who are the leading players in the Dutch pet healthcare market?
7.3. Which companies have been most successful in increasing their market share since 2014?
7.4. What are the most popular brands in the market?
8 Company Profiles
8.1. Bayer AG
8.2. Rolf C. Hagen Inc
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related research
10.4. About the Author
List of Tables
Table 1: Netherlands pet healthcare market value: $ million, 2014-18
Table 2: Netherlands pet healthcare market volume: million units, 2014-18
Table 3: Netherlands pet healthcare market category segmentation: $ million, 2018
Table 4: Netherlands pet healthcare market geography segmentation: $ million, 2018
Table 5: Netherlands pet healthcare market distribution: % share, by value, 2018
Table 6: Netherlands pet healthcare market value forecast: $ million, 2018-23
Table 7: Netherlands pet healthcare market volume forecast: million units, 2018-23
Table 8: Netherlands pet healthcare market share: % share, by value, 2018
Table 9: Bayer AG: key facts
Table 10: Bayer AG: Annual Financial Ratios
Table 11: Bayer AG: Key Employees
Table 12: Bayer AG: Key Employees Continued
Table 13: Rolf C. Hagen Inc: key facts
Table 14: Rolf C. Hagen Inc: Key Employees
Table 15: Netherlands size of population (million), 2014-18
Table 16: Netherlands gdp (constant 2005 prices, $ billion), 2014-18
Table 17: Netherlands gdp (current prices, $ billion), 2014-18
Table 18: Netherlands inflation, 2014-18
Table 19: Netherlands consumer price index (absolute), 2014-18
Table 20: Netherlands exchange rate, 2014-18
List of Figures
Figure 1: Netherlands pet healthcare market value: $ million, 2014-18
Figure 2: Netherlands pet healthcare market volume: million units, 2014-18
Figure 3: Netherlands pet healthcare market category segmentation: % share, by value, 2018
Figure 4: Netherlands pet healthcare market geography segmentation: % share, by value, 2018
Figure 5: Netherlands pet healthcare market distribution: % share, by value, 2018
Figure 6: Netherlands pet healthcare market value forecast: $ million, 2018-23
Figure 7: Netherlands pet healthcare market volume forecast: million units, 2018-23
Figure 8: Forces driving competition in the pet healthcare market in the Netherlands, 2018
Figure 9: Drivers of buyer power in the pet healthcare market in the Netherlands, 2018
Figure 10: Drivers of supplier power in the pet healthcare market in the Netherlands, 2018
Figure 11: Factors influencing the likelihood of new entrants in the pet healthcare market in the Netherlands, 2018
Figure 12: Factors influencing the threat of substitutes in the pet healthcare market in the Netherlands, 2018
Figure 13: Drivers of degree of rivalry in the pet healthcare market in the Netherlands, 2018
Figure 14: Netherlands pet healthcare market share: % share, by value, 2018

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Bayer AG
  • Rolf C. Hagen Inc